Skip to main content

Table 1 Basic characteristics

From: Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients

Characteristic

Number

%

Age

 < 65

20

50.0

 ≥ 65

20

50.0

Sex

Male

28

70.0

Female

12

30.0

KPS

 < 80

20

50.0

 ≥ 80

20

50.0

Primary tumour location

Oral cavity

21

52.5

Larynx

8

20.0

Maxillary sinusnasal cavity

3

7.5

Hypopharynx

6

15.0

Oropharynx

2

5.0

Disease status

Distant metastasis

16

40

Local recurrence

22

55

Recurrence and metastasis

2

5

No. of metastasis

1–5

10

55.6

 > 5

8

44.4

Sites of metastasis

Liver

6

22.2

Lung

13

48.1

Brain

2

7.4

Mediastinal LN

3

11.1

Bone

3

11.1

PD-L1 status

Negative

20

50.0

Positive

20

50.0

  1. KPS Karnofsky Performance Status, LN Lymph node, PD-L1 Programmed cell death ligand 1, PD-1 Programmed cell death 1